Celcarb 150 mg Injection 1's
Celon Laboratories Ltd
CARBOPLATIN-150MG
PARENTERAL
In Stock
Celcarb 150 mg Injection 1's belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
Celcarb 150 mg Injection 1's contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.
Celcarb 150 mg Injection 1's is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Celcarb 150 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
To treat your condition effectually, continue taking Celcarb 150 mg Injection 1's for as long as your doctor has prescribed. Do not stop the Celcarb 150 mg Injection 1's midway. Talk to your doctor before taking Celcarb 150 mg Injection 1's if you have severe allergic reactions to Celcarb 150 mg Injection 1's or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Celcarb 150 mg Injection 1's should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Celcarb 150 mg Injection 1's if you are pregnant or breastfeeding because this Celcarb 150 mg Injection 1's can cause harmful effects on the unborn baby. Both women and men using this Celcarb 150 mg Injection 1's should use birth control to avoid pregnancy.
Ovarian cancer and Small cell lung cancer
Celcarb 150 mg Injection 1's contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
Celcarb 150 mg Injection 1's should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Celcarb 150 mg Injection 1's. To treat your condition effectually, continue taking Celcarb 150 mg Injection 1's for as long as your doctor has prescribed. Do not stop the Celcarb 150 mg Injection 1's midway. Talk to your doctor before taking Celcarb 150 mg Injection 1's if you have severe allergic reactions to Celcarb 150 mg Injection 1's or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Celcarb 150 mg Injection 1's should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Celcarb 150 mg Injection 1's if you are pregnant or breastfeeding because this Celcarb 150 mg Injection 1's can cause harmful effects on the unborn baby. Both women and men using this Celcarb 150 mg Injection 1's should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Celcarb 150 mg Injection 1's treatment and appropriate until recovery is achieved.
Drug-Drug Interactions: Celcarb 150 mg Injection 1's interacts with medicines used in the treatment of chemotherapy (e.g. pemetrexed, gemcitabine, pegfilgrastim, paclitaxel, docetaxel), antacid medications (e.g. pantoprazole) and antibiotic medications (e.g. amikacin, gentamicin, kanamycin, streptomycin, tobramycin).
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking Celcarb 150 mg Injection 1's it requires close monitoring if you are suffering from Infection (bacterial/fungal/protozoal/viral), bleeding disorders, bone marrow depression/low blood counts, fever, renal dysfunction or disorders, peripheral neuropathy (nerves malfunction).
You are recommended to avoid alcohol consumption while taking Celcarb 150 mg Injection 1's. It could lead to avoiding unpleasant side effects.
Celcarb 150 mg Injection 1's should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking Celcarb 150 mg Injection 1's and at least six months afterwards. Please consult your doctor about any concerns regarding this.
Celcarb 150 mg Injection 1's should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers. Please consult your doctor about any concerns regarding this.
Celcarb 150 mg Injection 1's may affect your reactions and your ability to drive. Possible side effects of chemotherapy with Celcarb 150 mg Injection 1's may occur, such as nausea and vomiting. If you are affected by these side effects, you should not drive and/or operate machines that require you to be alert.
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking Celcarb 150 mg Injection 1's. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking Celcarb 150 mg Injection 1's. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Efficacy and safety have not been established. Please consult your doctor. Your doctor will weigh the benefits and potential risks before prescribing them.
This item is Not Returnable.
Expires on or after - Mar-23
Ovarian cancer: Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed).
Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
Celcarb 150 mg Injection 1's contains 'Carboplatin'. Carboplatin works by breaching the cellular wall and binding to the cell’s DNA, preventing the cell from dividing and functioning normally, which eventually kills the cell.
Yes, Celcarb 150 mg Injection 1's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.
Celcarb 150 mg Injection 1's should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
Before you receive treatment with Celcarb 150 mg Injection 1's, tell your doctor about all of your medical conditions. You should not receive Celcarb 150 mg Injection 1's if you are allergic to carboplatin or any contents in Celcarb 150 mg Injection 1's. It should not be employed in patients with severe bone marrow depression or significant bleeding.
If not given an inappropriate dose, Celcarb 150 mg Injection 1's can cause toxic effects, although not everyone gets it. So, Celcarb 150 mg Injection 1's is prescribed by a doctor experienced in the use of medications to treat cancer only.
Avoid taking Celcarb 150 mg Injection 1's if you are pregnant because Celcarb 150 mg Injection 1's can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Celcarb 150 mg Injection 1's.
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
(Inclusive of all taxes)
Provide Delivery Location
Vial
1 Injection in 1 Vial